NEW EHV INSERTION SITE ORF70

The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site ORF70. The present invention further concerns related expression cassettes and vectors,which are suitable to express genes of interest, especially antigen encoding sequences. The viral vec...

Full description

Saved in:
Bibliographic Details
Main Authors GALLEI ANDREAS, REHMET KRISTINA, MUNDT ALICE
Format Patent
LanguageChinese
English
Published 03.05.2019
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the field of (vector) vaccines, and especially to the novel EHV insertion site ORF70. The present invention further concerns related expression cassettes and vectors,which are suitable to express genes of interest, especially antigen encoding sequences. The viral vectors of the present invention are useful for producing an immunogenic composition or vaccine. 本发明涉及(载体)疫苗的领域，且尤其涉及新的EHV插入位点ORF70。本发明进一步涉及适于表达所关注的基因，尤其抗原编码序列的相关表达盒及载体。本发明的病毒载体可用于产生免疫原性组合物或疫苗。
Bibliography:Application Number: CN201780057791